Synpha Biosciences
Synpha Biosciences is an early-stage biotechnology company focused on developing synthetic phage therapeutics to treat bacterial diseases. They leverage patent-protected technology combined with a machine learning AI platform to create advanced therapies that address challenges in traditional phage therapy. The company is based at the University of Wisconsin-Madison and is currently seeking funding to advance its vision.
Synpha Biosciences
Synpha Biosciences is an early-stage biotechnology company focused on developing synthetic phage therapeutics to treat bacterial diseases. They leverage patent-protected technology combined with a machine learning AI platform to create advanced therapies that address challenges in traditional phage therapy. The company is based at the University of Wisconsin-Madison and is currently seeking funding to advance its vision.